Lamb Weston's Q2 financial results, released today, recorded net sales of $1.60bn, down 8% year-on-year.

CarMax reported better-than-expected third-quarter results as lower prices helped boost demand.

Wall Street’s dip buying spree on Thursday was already wearing thin in the first half-hour of trading. After the Dow spiked more than 400 points, it was up just 200 points, or 0.5%, shortly after 10 a.m. ET. The S&P 500 was up 0.5% and the Nasdaq Composite was up 0.6%.

Bleak consumer demand and pricing pressures overshadow AI-driven growth, sparking a sell-off in semiconductor stocks

This acquisition was made under an agreement with CMH and Anna-Rosa Giglio.

Businesses are placing an emphasis on scaling their AI projects and digitizing their core operations as well as data security to increase growth and cut costs, and companies such as Accenture are reaping the benefits. Accenture is leveraging GenerativeAI across industries to help clients optimize operations, from predictive maintenance in manufacturing to automating workflow in advertising operations, the company said in a post-earnings call. The IT provider said it has increased its data and AI workforce to 69,000 and plans to reach 80,000 by 2026, indicating growing demand for its services.

Hims stock skidded Thursday after the FDA determined Eli Lilly's tirzepatide — which sells as a weight-loss drug — is no longer in shortage.

Vertex Pharmaceuticals shares sank Thursday after the company reported mixed results in a Phase 2 drug trial to treat lumbosacral radiculopathy (LSR), which causes leg and back pain.

Vertex stock plummeted Thursday after the company's pain drug proved it's no better than a placebo in patients with lower back and hip pain.

Mizuho analyst forecasts 50% upside for Robinhood, citing strong brand appeal and long-term growth potential